Skip to search formSkip to main contentSkip to account menu

tertatolol

Known as: 1-((3,4-Dihydro-2H-1-benzothiopyran-8-yl)oxy)-3-((1,1-dimethylethyl)amino)-2-propanol, 2-propanol, 1-((3,40dihydro-2H-1-benzothiopyran-8-yl)oxy)-3-((1,1-dimethylethyl)amino)-, Racemic Teraterol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
SummaryThe potential 5-HT1A antagonist properties of the ß-antagonist tertatolol were assessed using biochemical and… 
1988
1988
We have previously reported that a potent new beta-blocker, tertatolol, when given at therapeutic doses to healthy volunteers… 
1986
1986
Tertatolol is a potent new β‐blocker with no intrinsic sympathomimetic activity or β1/β2‐receptor subtype selectivity. When given… 
1986
1986
Tertatolol, a new beta-blocker, and propranolol, considered a reference beta-blocker, were given orally (5 and 160 mg slow… 
Review
1986
Review
1986
Tertatolol is rapidly (tmax: 1.25 h) and totally absorbed by the gastro-intestinal tract with a low presystemic metabolism, and…